Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16K | Jun 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KYMR | Kymera Therapeutics, Inc. | Jun 18, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
KYMR | Kymera Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
KYMR | Kymera Therapeutics, Inc. | Jul 6, 2022 | 1 | $0 | 4 | Jul 8, 2022 | Director |
KYMR | Kymera Therapeutics, Inc. | Jul 6, 2022 | 0 | $0 | 3 | Jul 8, 2022 | Director |